Aterian, Inc. current report, 24 April 2023

全文

Aterian, Inc. Form 8-K Summary

Business Context and Reporting Period

Aterian, Inc. filed this Current Report on Form 8-K regarding a Nasdaq listing compliance matter. The earliest reported event occurred on April 24, 2023; the filing was signed on April 28, 2023. The company’s common stock trades under the symbol ATER on the Nasdaq Capital Market.

Key Financial Metrics and Liquidity

This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating or financial metrics.

Material Change Versus Prior Period

On April 24, 2023, Nasdaq notified the company that its common stock had closed below the required minimum bid price of $1.00 per share for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). The filing does not provide comparable-period financial information.

Guidance, Outlook, Risks, and Unusual Items

  • The notice had no immediate effect on the company’s Nasdaq listing, which remained fully effective.
  • Aterian received 180 calendar days, through October 23, 2023, to regain compliance.
  • Compliance generally requires a closing bid price of at least $1.00 for a minimum of 10 consecutive business days, subject to Nasdaq’s discretion to require up to 20 consecutive business days.
  • If compliance is not regained, Nasdaq may grant a second 180-day compliance period if the company satisfies applicable market-value and other initial listing requirements and notifies Nasdaq of its intent to cure the deficiency.
  • If the company fails to regain compliance within the available periods, Nasdaq may issue a delisting determination. The company would have the right to appeal to a Nasdaq hearings panel.
  • Management stated that it will monitor the stock’s closing bid price and seek to regain compliance, but cautioned that there is no assurance it will do so or obtain a second compliance period.

Important Facts for Investors to Verify

  1. Whether Aterian regained compliance by October 23, 2023 or received a second compliance period.
  2. Whether Nasdaq subsequently issued any delisting notice or the company appealed such a determination.
  3. The company’s compliance with other Nasdaq continued-listing requirements, including the market value of publicly held shares.
  4. Any subsequent actions affecting the stock price or share count, including a reverse stock split or other capital-markets transaction.